tiprankstipranks
Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market

Cyclerion Therapeutics (CYCN) Income Statement

Compare
238 Followers

Cyclerion Therapeutics Income Statement

Last quarter (Q4 2024), Cyclerion Therapeutics's total revenue was $1.81M, an increase of Infinity% from the same quarter last year. In Q4, Cyclerion Therapeutics's net income was $530.00K. See Cyclerion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.00M$ 0.00$ 297.00K$ 3.32M$ 2.30M
Gross Profit
$ 2.00M$ 0.00$ 232.00K$ 2.85M$ 2.30M
Operating Expenses
$ 5.63M$ 9.65M$ 44.67M$ 57.63M$ 85.23M
Depreciation and Amortization
$ 0.00$ -2.95M$ 65.00K$ 472.00K$ 2.30M
EBITDA
$ -3.63M$ -12.59M$ -18.18M$ -55.20M$ -81.27M
Operating Income
$ -3.63M$ -9.65M$ -44.37M$ -55.20M$ -81.27M
Other Income/Expenses
$ 571.00K$ -2.95M$ 294.00K$ 3.55M$ 3.46M
Pretax Income
$ -3.06M$ -12.59M$ -44.08M$ -51.65M$ -77.80M
Net Income
$ -3.06M$ -21.02M$ -43.78M$ -51.66M$ -72.67M
Per Share Metrics
Basic EPS
$ -1.21$ -8.99$ -20.15$ -26.40$ -47.80
Diluted EPS
$ -1.21$ -8.99$ -20.15$ -26.40$ -47.80
Weighted Average Shares Outstanding
2.52M 2.34M 2.17M 1.96M 1.52M
Weighted Average Shares Outstanding (Diluted)
2.52M 2.34M 2.17M 1.96M 1.52M
Currency in USD

Cyclerion Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis